Mevacor and Allergic rhinitis - a phase IV clinical study of FDA data

Summary:

Allergic rhinitis is reported as a side effect among people who take Mevacor (lovastatin), especially for people who are male, 60+ old, also take Fosamax, and have Osteoporosis.

The phase IV clinical study analyzes which people have Allergic rhinitis when taking Mevacor. It is created by eHealthMe based on reports of 4,917 people who have side effects when taking Mevacor from the FDA, and is updated regularly.

What is Mevacor?

Mevacor has active ingredients of lovastatin. It is often used in high blood cholesterol. eHealthMe is studying from 4,988 Mevacor users. Check the latest studies of Mevacor.

What is Allergic rhinitis?

Allergic rhinitis is found to be associated with 906 drugs and 1,317 conditions by eHealthMe. Check the latest studies of Allergic rhinitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

4,917 people reported to have side effects when taking Mevacor.
Among them, 17 people (0.35%) have Allergic rhinitis.

Among these 17 people:

What is the gender of people who have Allergic rhinitis when taking Mevacor? *

female: 25 %
male: 75 %

What is the age of people who have Allergic rhinitis when taking Mevacor? *

What are other drugs people take besides Mevacor? *

What are other side effects people have besides Allergic rhinitis? *

Stress And Anxiety: 13 people, 76.47%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 64.71%
Back Pain: 9 people, 52.94%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 9 people, 52.94%
Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 8 people, 47.06%
Pleural Effusion (water on the lungs): 8 people, 47.06%
Dyspnea (difficult or laboured breathing): 8 people, 47.06%
Dizziness: 8 people, 47.06%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 7 people, 41.18%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 7 people, 41.18%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 7 people, 41.18%
Osteopenia (a condition where bone mineral density is lower than normal): 1 person, 5.88%
Bone Disorder: 1 person, 5.88%
Aneurysmal Bone Cyst (benign expansile tumour-like bone lesion of uncertain etiology, composed of numerous blood filled channels): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Mevacor and have Allergic rhinitis?

- Check whether Allergic rhinitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mevacor:

Mevacor (4,988 reports)

Browse all side effects of Mevacor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Allergic rhinitis:

Allergic rhinitis (906 drugs)

Browse all the conditions that are associated with Allergic rhinitis:

Allergic rhinitis (1,317 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lovastatin (the active ingredients of Mevacor) and Mevacor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.